EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma

Eryn Blass, Derin B Keskin, Chloe R Tu, Cleo Forman, Allison Vanasse, Haley E Sax, Bohoon Shim, Vipheaviny Chea, Nawoo Kim, Isabel Carulli, Jackson Southard, Haoxiang Lyu und 32 weitere

Cell · 2025-09 · 188 (19) · 5125-5141.e27

DOI: 10.1016/j.cell.2025.06.019 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Cell, 2025-09. Verfasst von Eryn Blass und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Melanoma, Cancer Vaccines, Antigens, Neoplasm, Adjuvants, Immunologic. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaCancer VaccinesAntigens, NeoplasmAdjuvants, ImmunologicHumansCD8-Positive T-LymphocytesIpilimumabNivolumabFemaleReceptors, Antigen, T-CellMaleMiddle Aged

Stichwörter der Autor:innen

T cellcancer vaccinesimmunotherapymelanomamutationneoantigenpersonalizedvaccine

Substanzen

Cancer VaccinesAntigens, NeoplasmIpilimumabNivolumabAdjuvants, ImmunologicReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Camb…
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Blass, E., Keskin, D. B., Tu, C. R., Forman, C., Vanasse, A., Sax, H. E., Shim, B., Chea, V., Kim, N., Carulli, I., Southard, J., Lyu, H., Lu, W., Rickles-Young, M., Afeyan, A. B., Olive, O., Mehndiratta, A., Greenslade, H., Shetty, K., …, & Ott, P. A. (2025). A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma. Cell, 188(19), 5125-5141.e27. https://doi.org/10.1016/j.cell.2025.06.019

Vancouver

Blass E, Keskin DB, Tu CR, Forman C, Vanasse A, Sax HE, et al. A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma. Cell. 2025;188(19):5125-5141.e27. doi:10.1016/j.cell.2025.06.019

BibTeX
@article{Blass2025,
  author = {Blass, Eryn and Keskin, Derin B and Tu, Chloe R and Forman, Cleo and Vanasse, Allison and Sax, Haley E and Shim, Bohoon and Chea, Vipheaviny and Kim, Nawoo and Carulli, Isabel and Southard, Jackson and Lyu, Haoxiang and Lu, Wesley and Rickles-Young, Micah and Afeyan, Alexander B and Olive, Oriol and Mehndiratta, Ambica and Greenslade, Haley and Shetty, Keerthi and Baginska, Joanna and Gomez Diaz, Ilana and Nau, Allison and Pfaff, Kathleen L and Gans, Andrew and Ranasinghe, Srinika and Buchbinder, Elizabeth I and Sussman, Tamara A and Insco, Megan L and Yoon, Charles H and Rodig, Scott J and Shukla, Sachet A and Li, Shuqiang and Aster, Jon C and Braun, David A and Cibulskis, Carrie and Hacohen, Nir and Neuberg, Donna S and Giobbie-Hurder, Anita and Livak, Kenneth J and Fritsch, Edward F and Oliveira, Giacomo and Simon, Jeremy M and Wu, Catherine J and Ott, Patrick A},
  title = {A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {19},
  pages = {5125--5141.e27},
  doi = {10.1016/j.cell.2025.06.019}
}
Kostenlos starten →